Plaintiff Whitacre Partnership, an Illinois limited partnership (plaintiff or Whitacre Partnership), seeks a declaration establishing its ownership of 1,000,000 shares of common stock in defendant Biosignia, Inc. (defendant or Biosignia). In the alternative, plaintiff seeks damages for the wrongful conversion of the stock. On 28 June 2001, defendants moved for summary judgment on the ground that the doctrine of judicial estoppel precluded plaintiff from asserting a factual position contrary to earlier representations made by plaintiff’s general partners before a bankruptcy tribunal. The trial court concluded there was no genuine issue of material fact and granted defendant’s motion for summary judgment. The Court of Appeals determined that judicial estoppel did not apply on the facts of the present case and remanded to the trial court. We modify and affirm.
I.
The facts of the instant case may be summarized as follows. Whitacre Partnership is an Illinois limited partnership. Its general *5 partners are Mark E. Whitacre and Ginger L. Whitacre (collectively “the Whitacres”), and its limited partners are the Whitacres’ three children, Alexander R. Whitacre, William A. Whitacre, and Tanya M. Whitacre (collectively “the Whitacre children”). The Whitacres, as general partners, each hold a one percent interest in the family partnership. The Whitacre children collectively own a ninety-eight percent interest as limited partners. According to the deposition testimony of Mark E. Whitacre (Whitacre), “[t]he Whitacre Partnership was meant to be a trust fund” for the benefit of the Whitacre children. At all times since the partnership was formed, its sole asset has been whatever right or title it may have had in the stock at issue in the present case.
Biosignia is a closely held Delaware biotech corporation registered as a foreign corporation doing business in North Carolina. Its principal place of business is Orange County, North Carolina. Biosignia’s corporate predecessors include Advocacy Communications, Inc. (Advocacy), also known by its trade name, Fúture Health Technologies, Inc. (FHT), 1 and Biomar International, Inc. (Biomar). Defendants T. Nelson Campbell and T. Colin Campbell (the Campbell defendants) are officers and directors of Biosignia and its predecessor companies.
On 1 October 1995, Whitacre was appointed director, President, and Chief Executive Officer of FHT, and Advocacy issued 250 shares of common stock to Whitacre in his name. The employment agreement reached between Whitacre and FHT on or prior to 1 October 1995 was memorialized in a letter dated 12 October 1995 and signed by both Whitacre and defendant T. Colin Campbell. The letter provided that Whitacre would receive, in addition to his salary, “20% of the outstanding shares of FHT by the date of FHT’s first private placement,” conditioned on Whitacre’s contribution of $150,000 to FHT and his “not [having] voluntarily retired from [his] position of CEO or *6 otherwise terminated [his] continuing relationship to FHT” as of the date of the first private placement. By the terms of the letter, the shares would be issued to Whitacre “and/or any trust established on behalf of [his] children.” On 1 January 1996, Whitacre transferred his 250 shares in Advocacy to Whitacre Partnership.
On 26 April 1996, Advocacy’s Board of Directors and shareholders executed a “Unanimous Written Consent in Lieu of a Joint Special Meeting” (Unanimous Written Consent). Whitacre signed as a director and on behalf of Whitacre Partnership as a shareholder of Advocacy. The Campbell defendants signed as directors and individually as shareholders. The Unanimous Written Consent (1) ratified Advocacy’s hiring of Whitacre as President and CEO of the corporation and the issuance of 250 shares of Advocacy stock to Whitacre; (2) acknowledged that the value of those shares as of 1 October 1995 was $150,000, and that they “represented] 20% of total ownership” of Advocacy and were issued for reimbursable expenses incurred on behalf of the corporation and as compensation for Whitacre’s services; and (3) authorized a share exchange for officers and counsel of the corporation at a rate of 8,000 “New Shares” for each “Old Share.”
On 29 April 1996, Advocacy filed a certificate of amendment with the Delaware Secretary of State to change its corporate name to “Biomar, International, Inc.” The following day Biomar issued stock certificate number 8 to Whitacre Partnership for 2,000,000 shares. No restrictive legend or other limiting indication appears on the face of the stock certificate. In a letter enclosing the certificate dated 25 September 1996, counsel for Biomar informed Whitacre that the new certificate “replace [d] the stock certificate of the original corporation, Advocacy Communications, Inc.” and that the “original of those certificates were marked cancelled and placed in the corporate book of Advocacy Communications, Inc.” 2
In early 1997, a federal grand jury indicted Whitacre on forty-five counts of tax fraud, wire fraud, money laundering, conspiracy, and other charges in connection with Whitacre’s embezzlement of several million dollars from his former employer, Archer-Daniels-Midland (ADM). Pursuant to a plea agreement, Whitacre pled guilty in October 1997 to thirty-seven counts of wire fraud, interstate transportation of stolen property, conspiracy to defraud, money laun *7 dering, and filing false tax returns in the United States District Court for the Central District of Illinois. On 4 March 1998, Whitacre was ordered to serve an active sentence of 108 months in a federal correctional facility and to pay over $11,000,000 in restitution. Shortly thereafter, in a separate federal proceeding, Whitacre was sentenced to an active term of thirty months for his participation in a price-fixing scheme during his tenure at ADM. In at least the former of the two criminal proceedings, as well as a bankruptcy proceeding initiated in September 1997, Whitacre was represented by Attorneys Bill T. Walker and Richard F. Kurth.
In January or February of 1997, upon Whitacre’s request, Biomar reissued 250,000 of the 2,000,000 shares held by Whitacre Partnership in the names of Whitacre’s attorneys, Walker and Kurth. Certificate number 18 was issued to Bill T. Walker and his spouse Susan P. Walker as joint tenants with a right of survivorship in the amount of 100,000 shares. Certificate number 19 was issued to Richard Kurth and his spouse Diane Kurth for 150,000 shares. Both certificates were issued sometime in 1997 and backdated to 3 September 1996, and both are listed in Biomar’s stock ledger as “transfer^]” from Whitacre Partnership. The record also reveals that a third stock certificate — certificate number 17, issued to Whitacre Partnership in the amount of 1,750,000 shares — was also dated 3 September 1996. The record is silent as to whether this certificate was also backdated, and the stock ledger entry describes certificate number 17 as a new issue for “shares retained” after a transfer of 250,000 shares. Taken together, certificates 17, 18, and 19 are consistent with T. Nelson Campbell and Whitacre’s contentions that Whitacre Partnership transferred 250,000 of its 2,000,000 shares in Biosignia to compensate Whitacre’s attorneys. Cumulatively, they reflect a 250,000-share reduction in Whitacre Partnership’s holding in Biosignia, an amount equivalent to the number of shares transferred to Whitacre’s attorneys as compensation for their services. All three certificates were signed by T. Nelson Campbell as Secretary/Treasurer of Biomar and by Mark E. Whitacre as President of Biomar.
On 11 February 1997, following his indictment by a federal grand jury and a brief period of hospitalization for what he characterized as “suicidal thoughts and erratic behavior,” Whitacre resigned as President and Chief Executive Officer of Biomar. In connection with his resignation, Whitacre accepted a position as an officer of Clintech, a new subsidiary of Biomar. In his letter of resignation to T. Nelson Campbell, Whitacre referred to a “previous understanding” *8 between Campbell and Whitacre whereby Whitacre’s resignation would “result in the forfeiture of 500,000 unearned shares of Biomar’s common stock.” The letter also expressed Whitacre’s understanding “that a new certificate will be issued in the amount of 1,250,000 shares,” and stated that a “copy of [Whitacre’s original] stock certificate” was attached. The letter requested that the new certificate be “issued to [Whitacre’s] children” in the name of W.F.P. Management Company (WFP), which Whitacre described as “the company holding my children’s estate (via a Family Limited Partnership).” W.F.P. Management, it appears, is simply another name for the Whitacre Family Partnership.
In a letter accepting Whitacre’s resignation dated 20 February 1997, T. Colin Campbell invited Whitacre’s approval to an expression of the “agreement between [Whitacre] and Biomar concerning [Whitacre’s] resignation.” The letter stated that “the total number of shares owned by [Whitacre’s] family partnership (prior to any share distributions to [Whitacre’s] attorneys) is 1,250,000 shares” and requested Whitacre to “indicate [his] approval by signing below.” Whitacre did sign the letter, just below Campbell’s signature, under the caption “AGREED TO.” The date “20 February 1997” also appears on the face of two separate stock certificates issued by Biomar to Whitacre Partnership. Stock certificate number 21, signed by T. Nelson Campbell as Secretary and T. Colin Campbell as President, was issued in the name of “W.F.P. Management Co., Inc.” in the amount of 1,000,000 shares. The ledger entry for certificate number 21 indicates that its issuance coincided with the purported surrender of 750,000 shares from certificate number 17, which was originally issued in the amount of 1,750,000 shares in the name of Whitacre Partnership. It is listed as a transfer from “Whitaker [sic] Partnership.” Stock certificate number 27, also signed by the Campbell defendants, was issued in the name of “Whitacre Partnership, a family partnership” in the amount of 1,000,000 shares. The stock ledger indicates that this was a transfer from WFP. In his 10 May 2001 deposition, Whitacre acknowledged that the date on certificate 21 was written in his own handwriting, and that the certificate “resulted from the discussions that [T. Nelson Campbell] and I had at my termination of employment with Biomar in February ;97.” Whitacre also acknowledged that he had signed a “contract” on 20 February 1997, under the terms of which he was to “forfeit 750,000 of those shares out of the 2,000,000.” 3
*9 In early 1997, Whitacre and T. Nelson Campbell executed a Restricted Stock Agreement (RSA), the scope and effect of which is crucial to a determination of the ownership of the stock at issue here. Although the agreement is dated 23 October 1995, the parties agree that the RSA was backdated to be given retroactive effect, and was not actually executed on 23 October 1995. The record is unclear, however, as to the actual date of execution.
The RSA purports to be a fully integrated agreement between Whitacre and T. Nelson Campbell, as an officer of FHT “or any other future name” of FHT, concerning the 2,000,000 shares issued to Whitacre. By its terms, the agreement is binding on the “parties . . . themselves, their successors and their assigns.” The RSA states that the company “hereby provides [Whitacre] 2,000,000 shares of its common stock . . . upon [Whitacre’s] joining the company . . . and for his continued employment as an officer of the Company or one of its subsidiaries/or joint ventures subject to the options and restrictions as specified below.” After expressing the parties’ desire to “restrict[] the sale, disposition, or other transfer” of Whitacre’s shares, it defines “Restricted Shares” to include “all outstanding Provided Shares” and defines “Provided Shares” as “the 2,000,000 Shares provided to [Whitacre] upon joining the Company.. . and for his continued employment as an officer of the Company or one of its subsidiaries/or joint ventures for a period of five years in order to be fully vested.”
On 4 March 1997, thirteen days after Biomar had accepted Whitacre’s resignation from FHT, T. Nelson Campbell and Whitacre executed an addendum to the 23 October 1995 RSA. In its entirety, the addendum provides as follows:
On March 4, 1997 this agreement was reached among the Principals of Biomar International, Inc. that Dr. Mark E. Whitacre would become the CEO/President of a subsidiary of Biomar to establish a joint venture company that will provide biostatistical services to pharmaceutical companies and HMOs. In this position, 1.25 million shares of stock (including the shares used to pay attorneys) will be maintained in the Whitacre Limited Partnership. 50% of the 1.25 million shares will be *10 vested in 1.5 years from the above date (3/4/97), and 100% within four years.
Defendants claim that this addendum to the vesting schedule originally laid out in the October 1995 RSA controls the disposition of this case.
On 11 September 1997, the Whitacres filed a voluntary petition for discharge of their debts under Chapter 7 of the United States Bankruptcy Code. In the course of their bankruptcy filings and statements before the bankruptcy trustee, the Whitacres made the following factual representations, which defendant maintains plaintiff is now estopped to contradict.
First, on the statutorily mandated “Schedule B”. disclosure of their personal property, the Whitacres appeared to acknowledge that the stock in question was subject to the 23 October 1995 RSA. Under the heading “Stock and interest in incorporated and unincorporated businesses,” the Whitacres listed “1.25 million shares of Biomar Stock maintained in Whitacre Limited Partnership conditioned on October 23, 1995 restricted stock agreement.” There is no corresponding entry for this stock in the “value” column. In the subsequent paragraph, titled “Interest in partnerships or joint ventures,” the Whitacres stated, “Debtors are general partners in Whitacre Limited Partnership with right to receive 1% each for administration. Management Company known as W.P. Management Company. Currently not funded.” The market value of this asset is listed as “UNKNOWN.”
Second, during the statutorily mandated “341 Meeting” 4 between debtors, creditors, and the bankruptcy trustee, Whitacre made additional statements, under oath, that appeared to acknowledge that the stock was subject to the 4 March 1997 Addendum to the RSA and that, given Whitacre’s resignation from the company, it could never vest in interest. The relevant portion of the transcript from that meeting reads as follows:
Mr. Yaeger [bankruptcy trustee]: You had a restricted stock agreement — and have provided me a copy of that — related to your employment as a chief executive officer where you were to receive 1.25 million shares of BioMar?
*11 Dr. Whitacre: Right.
Mr. Yaeger: What’s the status of that? Is that an asset your creditors can look to?
Dr. Whitacre: It’s an asset I won’t have because of a vesting schedule that is required — two and a half years to receive fifty percent of that, which would have been spring of next year, and five years to receive a hundred percent of that on a vesting schedule, so I will not receive that at this point.
Mr. Craven [counsel for Whitacre]: As a result of resigning 1, October.
Dr. Whitacre: Right. Resigning — -the October 1 resignation.
Mr. Yaeger: Does that stock have any present value?
Dr. Whitacre: It does not.
Mr. Yaeger: Are you owed anything by BioMar as a result of your employment or other contributions?
Dr. Whitacre: No, I received my last paycheck, and that’s it.
Eventually, the Whitacres’ bankruptcy petition was voluntarily dismissed. 5
Whitacre resigned from Clintech in October 1997, permanently ending his professional relationship with Biosignia, its predecessors, and its subsidiaries. Handwritten entries in the “transfer” columns of the stock ledger dated 1 October 1997 describe certificates 18, 19, and 27 — issued to Attorney Bill Walker, Attorney Richard Kurth, and Whitacre Partnership, respectively — as “VOID: Reverted to Biosignia, Inc.”
On 8 May 2000, Whitacre Partnership instituted the instant civil action against Biosignia, alleging wrongful cancellation of and, in the alternative, conversion of, 1,000,000 shares of stock, and seeking damages in excess of twenty million dollars. On 28 June 2001, after the close of discovery, Biosignia filed a motion for summary judgment, arguing that Whitacre Partnership was judicially estopped *12 to deny the earlier assertions of its general partners before a bankruptcy tribunal that the stock was subject to the RSA and its Addendum and, by the terms of those agreements, could never vest in plaintiff. On 13 July 2001, the trial court granted defendants’ motion for summary judgment. On 5 November 2002, the Court of Appeals reversed the trial court and remanded for adjudication on the merits. On 27 February 2003, this Court allowed discretionary review.
II.
The dispositive issue before this Court is whether the doctrine of judicial estoppel bars Whitacre Partnership from asserting ownership of the stock in question based on the Whitacres’ earlier representations before a bankruptcy tribunal. This case thus requires us to determine whether the doctrine of judicial estoppel is a part of the common law of North Carolina. We hold that it is, and hereby join at least thirty-five other states and the United States Supreme Court in recognizing the doctrine.
See New Hampshire v. Maine,
Before we describe the contours of the doctrine, we pause to consider the evolution of judicial estoppel, tracing its roots in the legal landscape of this Court and the United States Supreme Court. As this discussion will show, our recognition of judicial estoppel is not a point of departure, but a natural step in the evolution of our jurisprudence, consistent with well-established legal principles and settled precedent. Although we have not previously considered whether judicial estoppel is a viable doctrine in North Carolina, we have long applied several of its companion estoppel doctrines and have consistently recognized the importance of protecting the integrity of the judicial process from the vagaries of litigants who may seek to manipulate it.
See, e.g., Kannan v. Assad,
Broadly speaking, “estoppel is a bar which precludes a person from denying or asserting anything to the contrary of that which has, in contemplation of law, been established as the truth.” 28 Am. Jur. 2d
Estoppel and Waiver
§ 1 (2000). As we noted over 150 years ago, it is a principle which “lies at the foundation of all fair dealing between [persons], and without which, it would be impossible to administer law as a system.”
Armfield v. Moore,
While estoppel in its broadest sense predates the American colonial experience,
see Armfield,
Scholars have noted that the doctrine “has its roots in nineteenth century American law,” a period when preclusion law formed an “inconsistent patchwork,” and the phrase “judicial estoppel” was often used to refer to the emerging doctrines of res judicata and collateral estoppel. Lawrence B. Solum,
Caution! Estoppel Ahead: Cleveland v. Policy Management Systems Corporation,
32 Loy. L.A. L. Rev. 461, 475-76, 483 (1999) [hereinafter Solum]. By the early part of the twentieth century, the phrase was used loosely to refer to a variety of legal doctrines, including res judicata, collateral estoppel, equitable estoppel, quasi-estoppel, and election of remedies.
See, e.g., Aycock v. O’Brien,
North Carolina courts have recognized many of the doctrinal precursors of judicial estoppel in an evolving jurisprudence that has consistently disfavored reversals of position on factual matters to suit the exigencies of the moment. Our recognition of judicial estoppel is a natural extension of these doctrines, one which paral
*15
lels the development of a line of cases from the United States Supreme Court that culminated in
New Hampshire v. Maine,
We begin our survey of the historical roots of judicial estoppel with a discussion of res judicata and collateral estoppel. North Carolina recognizes both doctrines as traditionally formulated, although we have followed the modem trend in abandoning the strict “mutuality of estoppel” requirement for defensive uses of collateral estoppel.
Thomas M. McInnis & Assocs. v. Hall,
Under the doctrine of res judicata or “claim preclusion,” a final judgment on the merits in one action precludes a second suit based on the same cause of action between the same parties or their privies.
State ex rel. Tucker v. Frinzi,
Many authorities have noted that judicial estoppel is “closely related” to collateral estoppel, although “dissimilar in critical respects.”
Allen v. Zurich Ins. Co.,
North Carolina courts have also long recognized the doctrine of equitable estoppel, otherwise known as estoppel
in pais. In re Will of Covington,
“when any one, by his acts, representations, or admissions, or by his silence when he ought to speak out, intentionally or through culpable negligence induces another to believe certain- facts exist, and such other rightfully relies and acts on such belief, so that he will be prejudiced if the former is permitted to deny the existence of such facts.”
State Highway Comm’n. v. Thornton,
Equitable estoppel is closely related to judicial estoppel. Indeed, some authorities have described the latter as a subset or variation of the former.
See, e.g., Eads Hide & Wool Co. v. Merrill,
*18
This Court has also recognized that branch of equitable estoppel known as “quasi-estoppel” or “estoppel by benefit.”
Brooks v. Hackney,
In light of these distinctions, quasi-estoppel may be more closely related to judicial estoppel than any other equitable doctrine.
See
Anderson & Holober,
Despite this close connection, however, there are substantial differences between the doctrines, with quasi-estoppel appearing to occupy an intermediary position between judicial estoppel and equitable estoppel.
See
Anderson & Holober,
In sum, quasi-estoppel is similar to judicial estoppel in the absence of a requirement of detrimental reliance on the part of the party invoking the estoppel. Quasi-estoppel is similar to equitable estoppel in that it may not be invoked by a stranger to the transaction where the prior position was asserted. Thus, as with the other doctrines discussed above, quasi-estoppel overlaps judicial estoppel, but the doctrines are not redundant.
Finally, North Carolina courts have long recognized and applied the election of remedies doctrine.
E.g., Richardson v. Richardson,
Other authorities have recognized the close connection and essential differences between judicial estoppel and the doctrine of election.
See, e.g., United States v. Carrero,
In addition to invoking the specific estoppel doctrines described above, we have on other occasions estopped parties to assert inconsistent positions in the same or subsequent judicial proceeding without specifying the precise legal theory at work.
See, e.g., King v. Snyder,
*22 We do not propose that these cases applied the doctrine of judicial estoppel without denominating it as such. Rather, these cases evince the early stirrings of judicial estoppel in the case law of this state. The purpose and effect of the estoppels applied in these cases closely approximate the purpose and effect of judicial estoppel as it has been applied in most jurisdictions. We therefore draw upon these cases, in addition to all the others cited earlier, in recognizing that judicial estoppel is a part of the common law of this state.
We now turn to a close examination of the precedents cited in New Hampshire v. Maine in support of the United States Supreme Court’s articulation of the doctrine of judicial estoppel. Because we follow the Supreme Court’s reasoning in that case in our opinion today, we explore in some detail the manner in which the United States Supreme Court derived the rule of judicial estoppel from its own precedents.
In
New Hampshire,
the United States Supreme Court implicitly recognized the doctrine’s deep roots in American jurisprudence, beginning its discussion of the law of judicial estoppel with the following quotation from the 1895 case,
Davis v.
Wakelee: “ ‘Where a party assumes a certain position in a legal proceeding, and succeeds in maintaining that position, he may not thereafter, simply because his interests have changed, assume a contrary position, especially if it be to the prejudice of the party who has acquiesced in the position formerly taken ....’”
New Hampshire,
It is important to note that
Davis v. Wakelee,
cited in
New Hampshire v. Maine
as a statement of the law of judicial estoppel, never mentions the doctrine by name. Rather,
Davis v. Wakelee
states the rule as a “general principle” and cites two distinct lines of cases expounding the doctrine of equitable estoppel and the related doctrine of “mend the hold.”
*23
The first case cited in
Davis v. Wakelee
in support of the rule quoted above is
Philadelphia, Wilmington & Baltimore Co. R.R. v. Howard,
*24
This interpretation is bolstered by the statement in
Davis v. Wakelee
that estoppel is appropriate
“especially
if [the shift in position] be to the prejudice of the party who has acquiesced in the position formerly taken by him.”
The second case cited in
Davis v. Wakelee
in support of the rule articulated there is
Ry. Co. v. McCarthy,
McCarthy
is probably the earliest articulation of the “mend the hold” doctrine, an equitable doctrine that precludes the assertion of inconsistent litigation positions, usually concerning the meaning of a contract, within the context of a single lawsuit. Robert Sitkoff, Comment,
“Mend the Hold” and Erie: Why an Obscure Contracts Doctrine Should Control in Federal Diversity Cases,
65 U. Chi. L. Rev. 1059, 1064 (1998); Anderson
&
Holober,
In
Harbor Ins. Co. v. Cont’l Bank Corp.,
the United States Court of Appeals for the Seventh Circuit closely compared the doctrines of judicial estoppel and “mend the hold” and concluded that the two are “ cousin [s].”
Returning to an analysis of our own precedents, we believe that the evolution of our estoppel jurisprudence parallels that of the United States Supreme Court. We have already explained that the doctrine of equitable estoppel has deep roots in the jurisprudence of this state. In addition, we have recognized and approved the “mend the hold” rule, as stated by the United States Supreme Court in
McCarthy,
on at least two occasions.
Standard Accident Ins. Co. v. Harrison-Wright Co.,
As the United States Supreme Court did in
Wakelee,
we now draw upon our equitable estoppel and “mend the hold” precedents in support of our recognition of the doctrine of judicial estoppel. Although the doctrines are not equivalent, they substantially overlap and are motivated by a similar set of policy concerns. Anderson & Holober,
As the foregoing discussion demonstrates, North Carolina courts have previously recognized several doctrines that may be used, under prescribed circumstances, to preclude the assertion of inconsistent positions before a tribunal. Judicial estoppel, however, is distinguishable from its companion doctrines in two principle respects. First, judicial estoppel seeks to protect courts, not litigants, from individuals who would play “fast and loose” with the judicial system.
In re Cassidy,
Of course, there is no need for judicial estoppel where previously established doctrines would preclude the assertion of an inconsistent
*27
position.
See Estate of Burford v.
Burford,
III.
With this understanding of the nature and evolution of judicial estoppel in mind, we now turn to an analysis of the issues raised in this appeal. Because it is central to the disposition of this case, we begin with the question of how the doctrine of judicial estoppel should be applied in North Carolina. This is a question of first impression for this Court.
Plaintiff asks us to adopt the “narrow view” of judicial estoppel set forth in
Medicare Rentals, Inc. v. Advanced Servs.,
The Court of Appeals delineated two doctrinal variations of judicial estoppel in the instant proceeding. First, the Court of Appeals cited the Fourth Circuit case of
Sedlack v. Braswell Servs. Group
in formulating the “federal” test for judicial estoppel as follows: “This three-pronged test requires that (1) the estopped party assert a position that is factually inconsistent with that taken in prior litigation; (2) the estopped party intentionally misled the court to gain an unfair advantage; and (3) the prior position be accepted by the court.”
Whitacre P’ship v. Biosignia, Inc.,
While it is true that
Sedlack
described the three prongs of its test as “three elements [that] must always be satisfied,”
Sedlack,
In
New Hampshire v. Maine,
the United States Supreme Court applied the doctrine of judicial estoppel to preclude the State of New Hampshire from asserting that a portion of the New Hampshire-Maine border ran along the Maine shore when it had successfully argued in a previous action that the same portion of that border was located at the center of the Piscataqua River’s main navigable channel.
Applying these factors, the United States Supreme Court concluded that they “tip[ped] the balance of equities in favor of barring New Hampshire’s present complaint.”
Id.
The Court emphasized, however, that these three factors “do not establish inflexible prerequisites or an exhaustive formula for determining the applicability of judicial estoppel” and that “ [additional considerations may inform the doctrine’s application in specific factual contexts.”
Id.; cf. Zurich Ins. Co.,
We are persuaded that New Hampshire v. Maine best characterizes our common law doctrine of judicial estoppel and thus follow the United States Supreme Court’s doctrinal formulation without hesitation. With a view toward providing appropriate guidance to our trial courts in their application of judicial estoppel, however, we pause to observe two important limitations on our holding.
As an initial matter, our recognition of judicial estoppel is limited to civil proceedings. New Hampshire v. Maine did not squarely address the applicability of the doctrine in the criminal context, and we believe public policy considerations militate against extending the doctrine to that arena. We address this issue from two standpoints: (1) whether judicial estoppel may be applied against a criminal defendant and (2) whether judicial estoppel may be applied against the government in a criminal case.
First, judicial estoppel should not ordinarily be applied against a criminal defendant. Although the United States Supreme Court did cite three criminal cases in
New Hampshire v. Maine,
the Court took no express position on the applicability of judicial estoppel to criminal proceedings, and in none of these cases was judicial estoppel actually applied against a defendant.
See Russell,
The policies undergirding judicial estoppel must sometimes yield to countervailing policy concerns. As the Ninth Circuit has noted, given the high stakes of criminal prosecutions and the special protections traditionally afforded criminal defendants, “[j]ustice would not be served by holding [a criminal] defendant to [his or her] prior false statements, because to do so would assign a higher value to the
*31
‘sanctity of the oath’ than to the guilt or innocence of the accused.”
Morris v. California,
Second, judicial estoppel should not ordinarily be applied against the government in a criminal proceeding.
See, e.g., Thompson v. Calderon,
Next, we emphasize that our recognition of judicial estoppel is limited to the context of inconsistent factual assertions and that the doctrine should not be applied to prevent the assertion of inconsistent legal theories. Although not addressed in
New Hampshire v. Maine,
this limitation on the reach of judicial estoppel has been adopted by the majority of courts to consider the matter.
See, e.g., Wight v. BankAmerica Corp.,
Having delineated the doctrine of judicial estoppel, we now turn to an issue that concerns its application here. Plaintiff argues, and the Court of Appeals held, that judicial estoppel does not apply in this case because there was “no evidence that Dr. Whitacre intentionally misled the court” by “intentionally manipulat[ing] or hid[ing] the truth to gain an unfair advantage.”
Whitacre P’ship,
We are mindful that the application of judicial estoppel to preclude a party from making a
true
factual assertion in a later proceeding because it contradicts
a false
factual assertion made in an earlier one may be seen as interfering with the truth-seeking function of courts.
See Teledyne Indus., Inc. v. Nat’l Labor Relations Bd.,
Plaintiff next argues that Whitacre was acting in his individual capacity, and not as a general partner of Whitacre Partnership, when he filed his bankruptcy petition and gave testimony at the 341 meeting with the bankruptcy trustee and his creditors. According to plaintiff, North Carolina partnership law precludes an estoppel against Whitacre Partnership based on representations made by Whitacre during the bankruptcy proceeding. Because Whitacre was not “apparently carrying on in the usual way the business of the partnership of which he is a member,” plaintiff argues, his representations at the bankruptcy proceeding cannot “bind[] the partnership.” N.C.G.S. § 59-39(a) (2003). The Court of Appeals found this argument persuasive, holding that summary judgment was precluded because a genuine issue of material fact remained as to whether Whitacre’s statements at the 341 hearing were “ ‘for the purposes of [the partnership’s] business,’ and were made for ‘carrying on in the usual way the business of the partnership’, so as to bind the partnership.”
Whitacre P’ship,
The issue in the instant case, however, is not whether Whitacre was acting within his authority as a general partner of Whitacre Partnership when he represented to the bankruptcy court that Whitacre Partnership’s shares could never vest. Rather, the issue is whether plaintiff can be judicially estopped from asserting a position *35 in one legal proceeding contradictory to representations made by its general partners in an earlier legal proceeding. This issue, in turn, raises two additional questions: (1) whether judicial estoppel may be applied not just to the parties to a prior action but also to their “privies” and (2) whether plaintiff and its general partners are in “privity” with one another in this case.
Plaintiff suggests that under
New Hampshire v. Maine,
judicial estoppel applies only against a “party” who asserts inconsistent positions in subsequent legal proceedings. Because Whitacre Partnership was a not a party to the Whitacres’ bankruptcy proceeding, plaintiff appears to argue, Whitacre Partnership cannot be judicially estopped on the basis of the Whitacres’ representations in that proceeding. Plaintiff bases this argument on its observation that the United States Supreme Court in
New Hampshire
never mentioned “privity” or “privies” and referred throughout the opinion to the application of the doctrine against a “party” or “parties.” We think plaintiff makes too much of this observation. In
New Hampshire,
the United States Supreme Court did not discuss privity because it had no need to do so. In that case, the parties before the Court, the states of New Hampshire and Maine, had also been parties to the previous action in which the prior inconsistent statement was made.
New Hampshire,
In the present case, by contrast, we are faced with a corporation seeking to estop a partnership from contradicting prior representations made by the partnership’s general partners in a Chapter 7 bankruptcy proceeding. Since Whitacre Partnership itself was not a party to the bankruptcy proceeding, there is no mutuality of estoppel, and we are forced to decide whether a privity relationship may sustain the application of judicial estoppel.
This Court has consistently applied the privity concept to a variety of estoppel doctrines.
See, e.g., McInnis,
In deciding whether judicial estoppel applies not only to parties, but also to their privies, it is instructive to consider the rationale for applying the privity concept in the collateral estoppel context. Due process requires that persons be given a fair opportunity to litigate their legal rights. U.S. Const, amends. V, XIV;
Windsor v. McVeigh,
We observe that other courts have applied the privity concept to the doctrine of judicial estoppel.
See, e.g., In re Johnson,
We do not address whether the Whitacres, as general partners of Whitacre Partnership, were in privity with the partnership. Whether privity exists in a given case should generally be resolved by the trial court in the first instance.
See Lowell Staats Mining Co. v. Philadelphia Elec. Co.,
Moreover, we are unable to determine from the record what precise formulation of judicial estoppel the trial court applied to the facts of the instant case. Assuming that the trial court applied the law of judicial estoppel as it had been articulated by our appellate courts up to now,
see Medicare Rentals,
We note that a trial court’s application of judicial estoppel is reviewed for abuse of discretion.
See New Hampshire,
In conclusion, the doctrine of judicial estoppel is a part of the common law of this state. In the instant case, however, the trial court did not have the benefit of the precise formulation of the doctrine we articulate in this opinion. Moreover, judicial estoppel is a discretionary doctrine, and the privity inquiry required here is a fact-intensive one. Thus, we instruct the trial judge on remand to determine whether the Whitacres and Whitacre Partnership are in privity and, if so, to exercise discretion in determining whether the doctrine of judicial estoppel is applicable in the instant case. Accordingly, we remand to the Court of Appeals for further remand to the trial court for further proceedings consistent with this opinion.
MODIFIED AND AFFIRMED.
Notes
. The Court of Appeals concluded that a genuine issue of material fact existed as to whether FHT was a “predecessor corporation to Advocacy” and stated that “[n]othing in the corporate documents in the record reflects FHT’s relationship, if any, to Advocacy, Biomar, Biosignia, or Clintech.” We disagree. The record is unequivocal on the question of Biosignia’s corporate lineage. Plaintiff’s own complaint specifically alleges that Biosignia is a “corporate successor” to FHT. Biosignia, in its answer, admits this factual allegation. In an affidavit attached to its summary judgment motion, Biosignia outlined its corporate history, explaining that FHT was “also known as” Advocacy and that Advocacy and Biomar were corporate predecessors of Biosignia. At no point has plaintiff denied any of this history. Finally, Whitacre expressly acknowledged in his deposition testimony that “Future Health Technologies, Biomar, and Biosignia all are one.”
. We note that the issuance of 2,000,000 shares to “replace]]” the original 250 shares issued by Advocacy is consistent with the share exchange ratio of 8,000 to 1 referred to in the Unanimous Written Consent.
. We note that there is a discrepancy in Whitacre’s representations as to how many shares he agreed to forfeit. While his resignation letter refers to the forfeiture of *9 500,000 shares, Whitacre’s deposition testimony corroborates Biosignia’s stock ledger and reflects a forfeiture of 750,000 shares. The latter figure is more consistent with plaintiff’s assertion that it owns 1,000,000, not 1,250,000, shares of Biosignia stock. Plaintiff’s original 2,000,000 share holding, less 250,000 shares to pay Whitacre’s attorneys and a forfeiture of 750,000 shares, leaves 1,000,000 shares remaining.
. Under section 341 of the Bankruptcy Code, the bankruptcy trustee must convene and preside over a meeting between the debtor, his or her creditors, and any equity security holders. During this meeting, the trustee must orally examine the debtor concerning the effects of a discharge in bankruptcy, the debtor’s ability to file a petition under a different chapter, and other matters. 11 U.S.C. § 341 (2000). The debtor must testify under oath at this examination. 11 U.S.C. § 343 (2000).
. Under the Bankruptcy Code, a voluntary dismissal is not at the debtor’s discretion. Upon motion by the debtor, the bankruptcy trustee may order dismissal only “for cause” following notice to creditors and a hearing. 11 U.S.C. § 707(a) (2000); 11 U.S.C. app., R. Bankr. P. 1017(a) (2000).
. We acknowledge that some of our older cases have articulated the doctrine of election in language sounding in estoppel
in pais,
where the facts would have supported application of either doctrine.
See, e.g., Holloman v. S. Ry. Co.,
. We note that among the three “factors” enumerated by the United States Supreme Court, the “clearly inconsistent” requirement alone appears to be an essential element which “must be” present in order for judicial estoppel to be applicable. The Court’s mandatory language (“must be”) supports this conclusion, as do a multitude of federal opinions that have explored this aspect of the doctrine.
See, e.g., Wight v. BankAmerica Corp.,
